B
Braidwell Portfolio holdings
AUM
$2.92B
This Quarter Return
+2.55%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.92B
AUM Growth
+$2.92B
(+2.8%)
Cap. Flow
+$71.1M
Cap. Flow
% of AUM
2.43%
Top 10 Holdings %
Top 10 Hldgs %
45.84%
Holding
71
New
6
Increased
13
Reduced
17
Closed
13
Top Buys
| 1 |
CAI
Caris Life Sciences, Inc. Common Stock
CAI
|
$195M |
| 2 |
Krystal Biotech
KRYS
|
$45M |
| 3 |
Edgewise Therapeutics
EWTX
|
$36.1M |
| 4 |
Inspire Medical Systems
INSP
|
$28.5M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$28M |
Top Sells
| 1 |
Transmedics
TMDX
|
$80.4M |
| 2 |
iRhythm Technologies
IRTC
|
$39.5M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$38.9M |
| 4 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
$28.2M |
| 5 |
Guardant Health
GH
|
$25.5M |
Sector Composition
| 1 | Healthcare | 71.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $30.5M | 1.04% |
1,102,580
-860,329
| -44% | -$23.8M |
|
27
Harrow
HROW
$1.44B
| $26.6M | 0.91% |
872,246
-84,593
| -9% | -$2.58M |
|
28
OrthoPediatrics
KIDS
$536M
| $23.8M | 0.81% |
1,107,770
| – | – |
|
29
Maravai LifeSciences
MRVI
$350M
| $20.1M | 0.69% |
8,353,287
| – | – |
|
30
Apellis Pharmaceuticals
APLS
$3.48B
| $19.4M | 0.66% |
1,121,034
-531,300
| -32% | -$9.2M |
|
|
SION
31
Sionna Therapeutics, Inc. Common Stock
SION
$1.09B
| $18.8M | 0.64% |
+1,081,855
| New | +$18.8M |
|
32
Madrigal Pharmaceuticals
MDGL
$9.76B
| $18.4M | 0.63% |
60,781
+12,091
| +25% | +$3.66M |
|
33
Repligen
RGEN
$6.88B
| $18M | 0.61% |
144,556
+62,900
| +77% | +$7.82M |
|
|
ORKA
34
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
| $17.1M | 0.58% |
1,524,842
-47,584
| -3% | -$533K |
|
35
Castle Biosciences
CSTL
$696M
| $16.8M | 0.57% |
822,735
+457,488
| +125% | +$9.34M |
|
36
UnitedHealth
UNH
$281B
| $15.4M | 0.53% |
+49,400
| New | +$15.4M |
|
37
Globus Medical
GMED
$8.27B
| $14.6M | 0.5% |
+247,200
| New | +$14.6M |
|
38
Day One Biopharmaceuticals
DAWN
$769M
| $14.2M | 0.49% |
2,181,598
-1,355,255
| -38% | -$8.81M |
|
39
Xencor
XNCR
$580M
| $13M | 0.45% |
1,655,690
| – | – |
|
40
Celcuity
CELC
$2.17B
| $11.8M | 0.4% |
884,306
| – | – |
|
|
CBIO
41
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
| $4.22M | 0.14% |
+261,504
| New | +$4.22M |
|
42
Replimune Group
REPL
$422M
| $3.93M | 0.13% |
422,887
-1,038,939
| -71% | -$9.65M |
|
43
Zura Bio
ZURA
$133M
| $2.6M | 0.09% |
2,472,806
| – | – |
|
44
Pulmonx
LUNG
$69.7M
| $1.95M | 0.07% |
752,541
| – | – |
|
45
Surrozen
SRZN
$104M
| $1.25M | 0.04% |
+140,000
| New | +$1.25M |
|
46
Ascendis Pharma
ASND
$11.8B
| – | – |
-106,713
| Closed | -$16.6M |
|
|
JBIO
47
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| – | – |
-1,440,499
| Closed | -$3.62M |
|
|
BPMC
48
DELISTED
Blueprint Medicines
BPMC
| – | – |
-439,968
| Closed | -$38.9M |
|
49
Cullinan Oncology
CGEM
$445M
| – | – |
-980,773
| Closed | -$7.42M |
|
50
Dianthus Therapeutics
DNTH
$759M
| – | – |
-375,355
| Closed | -$6.81M |
|